Second Hospital of Hebei Medical University Researchers Add New Data to Research in Cancer (Long non-coding RNA NMRAL2P promotes glycolysis and reduces ROS in head and neck tumors by interacting with the ENO1 protein and promoting GPX2...).
In: Clinical Oncology Week, 2023-10-17, S. 1040-1040
serialPeriodical
Zugriff:
Keywords: Cancer; Genetics; Health and Medicine; Oncology EN Cancer Genetics Health and Medicine Oncology 1040 1040 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Fresh data on cancer are presented in a new report. To prevent ROS from harming tumor cells, tumor cells can increase the production of reducing agents to counteract excessive ROS.". [Extracted from the article]
Copyright of Clinical Oncology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Second Hospital of Hebei Medical University Researchers Add New Data to Research in Cancer (Long non-coding RNA NMRAL2P promotes glycolysis and reduces ROS in head and neck tumors by interacting with the ENO1 protein and promoting GPX2...).
|
---|---|
Zeitschrift: | Clinical Oncology Week, 2023-10-17, S. 1040-1040 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6799 (print) |
Schlagwort: |
|
Sonstiges: |
|